Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Devos

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
JAMA Neurology|November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical TrialScott Ayton, David Barton, Bruce Brew, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trialCaroline Moreau, Pascal Odou, Julien Labreuche, et al.
Parkinsonism & Related Disorders|March 26, 2026
Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's diseaseRaquel Pinheiro Barbosa, Paulo Bastos, Matthieu Béreau, et al.
Neurobiology of Disease|July 13, 2024
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognitionVincent Huin, David Blum, Violette Delforge, et al.
Journal of Neurology|February 9, 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective studyRaquel Pinheiro Barbosa, Caroline Moreau, Anne Sophie Rolland, et al.
Plos One|January 7, 2021
Personality dimensions of patients can change during the course of parkinson's diseaseMathilde Boussac, Christophe Arbus, Julia Dupouy, et al.
Journal of Parkinson'S Disease|July 24, 2022
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover studyValérie Cochen De Cock, Pauline Dodet, Smaranda Leu-Semenescu, et al.
Journal of Parkinson'S Disease|June 27, 2025
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's diseaseMathilde Boussac, Florent Faggianelli, Estelle Harroch, et al.
Antioxidants & Redox Signaling|December 31, 2017
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?Caroline Moreau, Véronique Danel, Jean Christophe Devedjian, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
JAMA Neurology|November 4, 2024
Deferiprone in Alzheimer Disease: A Randomized Clinical TrialScott Ayton, David Barton, Bruce Brew, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular anaerobic dopamine in Parkinson's disease with L-dopa-related complications: a phase 1/2 randomized-controlled trialCaroline Moreau, Pascal Odou, Julien Labreuche, et al.
Parkinsonism & Related Disorders|March 26, 2026
Is being asymmetric a bad thing? Insights from a longitudinal observational study on STN-DBS Parkinson's diseaseRaquel Pinheiro Barbosa, Paulo Bastos, Matthieu Béreau, et al.
Neurobiology of Disease|July 13, 2024
Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognitionVincent Huin, David Blum, Violette Delforge, et al.
Journal of Neurology|February 9, 2024
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective studyRaquel Pinheiro Barbosa, Caroline Moreau, Anne Sophie Rolland, et al.
Plos One|January 7, 2021
Personality dimensions of patients can change during the course of parkinson's diseaseMathilde Boussac, Christophe Arbus, Julia Dupouy, et al.
Journal of Parkinson'S Disease|July 24, 2022
Can Dopamine Responsiveness Be Predicted in Parkinson's Disease Without an Acute Administration Test?Nacim Betrouni, Caroline Moreau, Anne-Sophie Rolland, et al.
The Lancet. Neurology|April 16, 2022
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover studyValérie Cochen De Cock, Pauline Dodet, Smaranda Leu-Semenescu, et al.
Journal of Parkinson'S Disease|June 27, 2025
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's diseaseMathilde Boussac, Florent Faggianelli, Estelle Harroch, et al.
Antioxidants & Redox Signaling|December 31, 2017
Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?Caroline Moreau, Véronique Danel, Jean Christophe Devedjian, et al.
Pageof 22